These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7484889)

  • 21. Chronic ACE inhibition enhances the endothelial control of arterial mechanics and flow-dependent vasodilatation in heart failure.
    Joannides R; Bizet-Nafeh C; Costentin A; Iacob M; Derumeaux G; Cribier A; Thuillez C
    Hypertension; 2001 Dec; 38(6):1446-50. PubMed ID: 11751733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Arterial effects of angiotensin converting enzyme inhibition in renovascular and spontaneously hypertensive rats.
    Levy BI; Michel JB; Salzmann JL; Azizi M; Poitevin P; Camilleri JP; Safar ME
    J Hypertens Suppl; 1988 Dec; 6(3):S23-5. PubMed ID: 3225686
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment for one year with perindopril: effect on cardiac mass and arterial compliance in essential hypertension.
    Asmar RG; Journo HJ; Lacolley PJ; Santoni JP; Billaud E; Levy BI; Safar ME
    J Hypertens Suppl; 1988 Dec; 6(3):S33-9. PubMed ID: 3225688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Angiotensin-converting enzyme inhibition by perindopril in the treatment of cardiovascular disease.
    Brugts JJ; Ferrari R; Simoons ML
    Expert Rev Cardiovasc Ther; 2009 Apr; 7(4):345-60. PubMed ID: 19379059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antihypertensive therapy and arterial function in experimental hypertension.
    Kähönen M; Arvola P; Mäkynen H; Pörsti I
    Gen Pharmacol; 1996 Mar; 27(2):221-38. PubMed ID: 8919635
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of aging on arterial compliance.
    Van Bortel LM; Spek JJ
    J Hum Hypertens; 1998 Sep; 12(9):583-6. PubMed ID: 9783484
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of antihypertensive drugs on large artery compliance.
    Slama M; Safavian A; Tual JL; Laurent S; Safar ME
    Neth J Med; 1995 Oct; 47(4):162-8. PubMed ID: 8538819
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beneficial effects of combination therapy with angiotensin II receptor blocker and angiotensin-converting enzyme inhibitor on vascular endothelial function.
    Morimoto S; Maki K; Aota Y; Sakuma T; Iwasaka T
    Hypertens Res; 2008 Aug; 31(8):1603-10. PubMed ID: 18971536
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vascular remodeling in systemic hypertension.
    Gohlke P; Lamberty V; Kuwer I; Bartenbach S; Schnell A; Unger T
    Am J Cardiol; 1993 Jun; 71(17):2E-7E. PubMed ID: 8392281
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pharmacological basis of antihypertensive drug therapy].
    Kolck UW; Zaugg CE; Erne P
    Praxis (Bern 1994); 2004 May; 93(20):847-56. PubMed ID: 15195836
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Evaluation of Antihypertensive Efficacy and Patient Adherence to Treatment With the New Formulation Perindopril Arginine (Orally Disintegrating Tablet) in General Clinical Practice: OPTIMUM Program].
    Glezer On Behalf Of The Optimum Program Participants MG
    Kardiologiia; 2016 Apr; 56(4):36-41. PubMed ID: 28294857
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Brachial pressure-independent reduction in carotid stiffness after long-term angiotensin-converting enzyme inhibition in diabetic hypertensives.
    Tropeano AI; Boutouyrie P; Pannier B; Joannides R; Balkestein E; Katsahian S; Laloux B; Thuillez C; Struijker-Boudier H; Laurent S
    Hypertension; 2006 Jul; 48(1):80-6. PubMed ID: 16702490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antihypertensive drugs and fibrinolytic function.
    Fogari R; Zoppi A
    Am J Hypertens; 2006 Dec; 19(12):1293-9. PubMed ID: 17161777
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Forearm arterial distensibility in patients with hypertension: comparative effects of long-term ACE inhibition and beta-blocking.
    De Cesaris R; Ranieri G; Filitti V; Andriani A; Bonfantino MV
    Clin Pharmacol Ther; 1993 Mar; 53(3):360-7. PubMed ID: 8384096
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dosage considerations with perindopril for systemic hypertension.
    Sica DA
    Am J Cardiol; 2001 Oct; 88(7A):13i-18i. PubMed ID: 11591356
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tissue angiotensin II and endothelin-1 modulate differently the response to flow in mesenteric resistance arteries of normotensive and spontaneously hypertensive rats.
    Matrougui K; Lévy BI; Henrion D
    Br J Pharmacol; 2000 Jun; 130(3):521-6. PubMed ID: 10821779
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Perindopril/indapamide combination in the first-line treatment of hypertension and end-organ protection.
    Gosse P
    Expert Rev Cardiovasc Ther; 2006 May; 4(3):319-33. PubMed ID: 16716093
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Arterial distensibility and left ventricular hypertrophy in patients with sustained essential hypertension.
    Girerd X; Laurent S; Pannier B; Asmar R; Safar M
    Am Heart J; 1991 Oct; 122(4 Pt 2):1210-4. PubMed ID: 1833966
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heterogeneity of response of peripheral arteries to antihypertensive drugs in essential hypertension. Basic effects and functional consequences.
    Levenson J; Simon A
    Drugs; 1988; 35 Suppl 5():34-9. PubMed ID: 3063483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiac hypertrophy and arterial compliance following drug treatment in hypertension.
    Asmar RG; Pannier BM; London GM; Safar ME
    J Cardiovasc Pharmacol; 1991; 18 Suppl 7():S37-9. PubMed ID: 1725199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.